🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of acetaminophen, claiming the firms withheld potential risks that the medication presented to pediatric cognitive development.

This legal action follows four weeks after President Donald Trump publicized an unsubstantiated connection between taking Tylenol - alternatively called acetaminophen - while pregnant and autism in young ones.

The attorney general is suing the pharmaceutical giant, which previously sold the drug, the only pain reliever suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he stated they "misled consumers by profiting off of suffering and pushing pills without regard for the dangers."

The company asserts there is lacking scientific proof tying acetaminophen to autism.

"These corporations deceived for years, deliberately risking countless individuals to boost earnings," the attorney general, a Republican, said.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its online platform, the company also said it had "continuously evaluated the pertinent research and there is insufficient valid information that shows a established connection between using paracetamol and autism."

Groups speaking for medical professionals and health professionals concur.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to treat pain and elevated temperature, which can pose major wellness concerns if ignored.

"In more than two decades of studies on the consumption of paracetamol in gestation, no reliable research has definitively established that the usage of paracetamol in any period of gestation leads to brain development issues in offspring," the organization commented.

This legal action mentions recent announcements from the former administration in claiming the medication is potentially dangerous.

Recently, Trump raised alarms from medical authorities when he advised pregnant women to "resist strongly" not to consume acetaminophen when sick.

The FDA then published an announcement that doctors should contemplate reducing the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in minors has not been established.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in April to conduct "comprehensive study program" that would determine the cause of autism in a matter of months.

But authorities warned that discovering a single cause of autism - thought by researchers to be the consequence of a intricate combination of inherited and surrounding conditions - would be difficult.

Autism is a category of enduring cognitive variation and impairment that influences how individuals experience and engage with the environment, and is diagnosed using doctors' observations.

In his court filing, Paxton - a Trump ally who is running for the Senate - claims the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the firms "eliminate any promotional materials" that claims acetaminophen is secure for women during pregnancy.

The court case mirrors the concerns of a collection of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in 2022.

A federal judge rejected the case, declaring studies from the parents' expert witnesses was lacking definitive proof.